What Should Founders Put on an AI Deal Diligence Checklist in 2026?

The Direct Answer: What Belongs on an AI Deal Diligence Checklist?

An AI deal diligence checklist should help a founder or operator test whether an AI product, company, acquisition target, or investment opportunity is commercially credible, technically reproducible, legally defensible, and operationally prepared for a transaction. The work is not simply a list of model files and customer testimonials. It must connect claims about automation and data advantages to measurable evidence such as gross margin after inference costs, renewal rates, customer concentration, model-evaluation results, data rights, cybersecurity controls, and the resources required to reproduce the product. In 2026, that matters because AI can alter both sides of a deal: it may make diligence faster, but it can also produce a misleading volume of superficially relevant evidence. Wolters Kluwer’s discussion of AI in legal due diligence and reports from BDO, Nasdaq’s Dasseti acquisition coverage, and PwC’s 2026 mid-year M&A outlook all point toward the same conclusion: AI is becoming part of the deal process, not a substitute for expert judgment.

Also worth reading: What is the definitive AI venture capital due diligence checklist for evaluating private startups in 2026? · How is AI transforming private markets due diligence for investors and founders? · Which AI Investor Diligence Metrics Should Founders Track Before Fundraising?

A useful checklist has four layers: product and technology, customers and economics, legal and regulatory readiness, and transaction execution. Each layer requires proof tied to a specific assertion. For example, “the model is accurate” is not enough; the buyer should ask for an evaluation set defined before testing, performance by customer segment, failure rates, human-review requirements, and results under distribution shifts. Likewise, “we own our data” requires contracts, provenance records, consent or licensing terms, and restrictions on training or resale. For founders, the objective is not merely to survive scrutiny. It is to identify weaknesses early, assign an owner and deadline to each gap, and decide which issues could change valuation, structure, or the willingness to proceed.

Why Traditional Due Diligence Is Not Enough for AI Deals

Conventional due diligence already reviews financial statements, contracts, intellectual property, employees, litigation, and compliance. Those categories remain necessary, but AI businesses require sharper questions because their value may depend on nontraditional assets. Software code alone may not capture the full product if the system also relies on proprietary data, feedback loops, evaluation methods, prompt or workflow design, orchestration logic, human processes, and third-party model services. A buyer must determine which of those assets are owned by the target, transferable after closing, and actually responsible for observed performance. A polished demonstration can hide manual review, curated datasets, or an expensive engineering team supporting every customer deployment.

AI also changes the speed and economics of a business. Cloud inference, vector storage, labeling, monitoring, retrieval, model serving, and safety review can create variable costs that do not appear clearly in conventional revenue metrics. A product with $10 million in annual recurring revenue is not necessarily attractive if each use of the product incurs $1 of inference cost and the contract does not permit usage-based repricing. The appropriate unit may be revenue per customer, per document, per transaction, or per completed workflow rather than revenue per seat. Buyers should calculate contribution margin by cohort and use case, then stress-test it under a 2x, 5x, and 10x increase in volume where the model behaves predictably.

The checklist must also distinguish claimed AI from economically meaningful AI. If removing the model does not change the customer’s result, or if the system mostly routes information without producing a measurable benefit, the AI label may be marketing rather than a source of defensibility. Conversely, a company can use third-party models and still possess meaningful value if it owns a difficult customer workflow, exclusive distribution channel, feedback dataset, or integration that competitors cannot easily reproduce. The issue is not whether a company trains its own foundation model. It is whether the target controls an advantage that customers will continue paying for after the acquisition.

How to Evaluate the Product, Model, and Technical Claims

Start with a reproducible product demonstration conducted on a buyer-controlled environment, ideally using real but appropriately protected examples. The founder should be prepared to show inputs, outputs, latency, failure modes, escalation rules, and the difference between automated and human-completed steps. Buyers should compare a baseline against the current system: a rules-based process, the prior model version, a competing product, and human performance where human performance matters. They should request metrics such as precision, recall, accuracy, false-positive rate, false-negative rate, calibration, task completion, and cost per successful outcome. A single aggregate accuracy figure is rarely sufficient because class imbalance can make a weak system appear strong.

Data evaluation is equally important. Ask how training, validation, and test data were selected, whether customer data is shared across accounts, whether test examples entered the training pipeline, and how performance changes over time. As of September 28, 2026, a target should be able to identify at least six common failure categories relevant to its business, explain their frequency, and show the controls used to detect them. The founder should also quantify latency and availability requirements by customer group. An internal assistant tolerating a 20-second response may be less defensible than a fraud workflow that must return a decision in under one second, but each has a different cost and reliability profile.

Technical diligence should test resilience rather than the best possible demo. Request evidence for vendor outage, model deprecation, API price changes, prompt injection, data poisoning, sensitive-data leakage, and the loss of a key engineer. Buyers should ask whether the system has fallback models, caching, version control, rollback procedures, observability, and incident-response ownership. If a target depends on one external model provider, document the contractual protections, substitution plan, and estimated migration period. No responsible buyer should assign full value to performance that disappears when a model version, cloud region, or API permission changes.

Customer, Revenue, and Unit-Economics Diligence

For each major customer, the diligence team should verify contract status rather than relying on a sales pipeline presented as recurring business. The review should distinguish signed annual contracts, multiyear commitments, monthly subscriptions, usage commitments, pilots, and letters of intent. Renewal rates should be calculated from comparable cohorts, with separate treatment for customers acquired through acquisitions, discounted pilots, and related-party sales. InvestmentNews’ reporting on how AI is changing the seller’s checklist is relevant here: buyers are increasingly asking how revenue is generated, what the product automates, and whether customers can reproduce the result without the vendor. A high logo count can obscure dependence on two or three accounts.

A practical concentration threshold is to investigate any customer representing more than 10% of trailing revenue, any customer representing more than 20% of current-quarter bookings, and any product dependency on fewer than three referenceable customers in a critical segment. These are not universal deal-breakers. They are prompts for deeper review of contracts, switching costs, security requirements, and renewal history. A buyer may accept concentration if the contract is prepaid, the customer has passed two renewal cycles, the use case is embedded in operations, and the target has credible expansion or cross-selling evidence.

Unit economics should follow the customer’s actual usage. Founders should present gross margin before and after model, cloud, data-labeling, support, and human-review costs. The analysis should include a baseline period, the last 12 months, and a forward scenario using management’s expected volume. For a transaction above $25 million, many teams will want monthly cohort reporting; for a smaller seed investment, a careful sample of customer-level invoices may be enough. The right level of detail depends on the amount at risk, the target’s stage, and the predictability of the cost structure. Ignoring this difference can make diligence either wasteful or dangerously shallow.

Legal, Data, Security, and Regulatory Readiness

The legal checklist must be tailored to what the AI system does, not to the fact that it uses AI. A healthcare scheduling assistant, a credit decisioning tool, an employment-screening product, and a customer-service bot face different questions about regulated data, decision rights, notice, testing, and human appeal. Founders should map each material model use case to the jurisdictions in which it is deployed, identify the controller, processor, vendor, and data-subject roles where applicable, and retain records showing which model version generated a consequential decision. The buyer should ask for current incident logs, customer complaints, regulator inquiries, and remediation plans rather than only a general privacy policy.

Data rights require documentary proof. Review source agreements, customer terms, public-data licenses, consent records, data-processing agreements, and restrictions on model training. Confirm whether the target can transfer data following a merger or asset sale, whether affiliates can use it, and whether deletion obligations are technically enforceable. A statement that customer data is “confidential” does not automatically mean the company owns it or can use it to train a model. The diligence team should test the distinction among ownership, license, permission, and contractual prohibition. Security evidence should include penetration-test dates, critical findings, access reviews, encryption practices, secrets management, backup recovery, and incident response exercises conducted within the previous 12 months.

Intellectual-property diligence should separate registered assets from know-how. Patents, trademarks, copyrights, trade secrets, code repositories, domain ownership, and contractor assignments should be checked. The target should explain what happens if a founder or engineer leaves, whether open-source obligations affect commercialization, and whether employee invention agreements cover relevant jurisdictions. Buyers should also inspect whether core prompts, datasets, evaluation sets, and orchestration code are stored in approved company systems. Missing documentation does not prove infringement, but it creates a valuation discount when the company cannot establish exclusive control over the assets supporting its price.

Cost, Pricing, and the Value of AI Diligence Tools

The cost of AI-assisted diligence varies by scope, data room quality, and the tools selected. A small company may use a review platform for a few thousand dollars per month, add specialist review at roughly $250 to $750 per hour, and spend $15,000 to $75,000 on a focused technology, legal, or commercial review. A broad diligence exercise for a middle-market or larger transaction can reach $100,000 or more once accounting for quality-of-earnings work, technical testing, privacy and security review, and transaction counsel. These are planning ranges rather than quoted prices; actual fees depend on complexity, urgency, and the independence required of the reviewers. Free or low-cost retrieval tools can help organize documents, but they should not be treated as a completed diligence process.

Nasdaq’s completion of its Dasseti transaction is a useful market signal because it illustrates how established transaction and diligence providers are incorporating AI capabilities into existing workflows. The likely value is faster document search, issue spotting, comparison of contract terms, and first-pass extraction. The likely limitation is that automated systems may miss ambiguous language, hidden inconsistencies, or technical claims that require a specialist to test. Juniper Square’s acquisition of Sightglass, as reported in the provided research context, similarly demonstrates interest in AI capabilities for private-market investor relations, although investor-relations automation and acquisition diligence are not identical use cases.

A better buying decision compares the tool’s cost with the value of the errors it prevents. A $20,000 annual subscription is unjustifiable if it merely summarizes a data room that a two-person team can review manually. It becomes more defensible if it accurately links thousands of documents to material inconsistencies, preserves citations, supports permissions, and allows reviewers to verify every conclusion. Before purchase, run a controlled pilot on historical deal documents, measure false positives and missed issues, test access controls, and require human approval for material findings. The tool should reduce review time without weakening confidentiality, privilege, or the ability to reproduce an investigation.

## Practical Steps Before a Deal Is Announced or Signed

First, create a claim-to-evidence matrix covering the 10 most important commercial, product, and financial assertions. Assign one owner to every claim and specify the document, dataset, interview, or test that will support it. The matrix should include a deadline, reviewer, status, financial exposure, and proposed remedy for every unresolved item. Founders should involve finance, engineering, legal, security, and customer-facing leaders in this preparation; otherwise, important gaps may remain in separate spreadsheets. A 60-day preparation sprint is reasonable for a typical private-company transaction, while a 30-day sprint may be enough for a small asset purchase, and a 90-day period may be justified for a target with complex regulated products.

Second, run a pre-mortem in which the team assumes the deal failed six months after closing and writes the likely reasons. Common explanations include an untransferable data license, customer concentration, inference costs exceeding expectations, a model dependency without a fallback, an unresolved security incident, or a founder who was essential to product performance. Each explanation should be converted into a diligence request and, where possible, a closing condition. Third, reconcile the data room with the financial and technical records. Revenue contracts should match customer names and invoice data, while production logs should support usage, uptime, and cost assumptions. Contradictions should be resolved before negotiation rather than treated as clerical issues.

Finally, decide which issues require a price adjustment, escrow, indemnity, milestone, covenant, or walk-away right. Not every uncertainty should stop a deal. A missing patent may matter less than customer retention; a regulator inquiry may matter more than a minor model-quality variance. The negotiation team should quantify the exposure using revenue at risk, remediation time, expected legal cost, and probability of occurrence. A 15% customer concentration issue with a credible retention plan is different from a 15% issue caused by a pending lawsuit or a nontransferable license. The purpose of preparation is to make those distinctions explicit while there is still time to change the structure.

Common Mistakes and When to Walk Away

The most common mistake is confusing document volume with diligence quality. A larger data room can create the appearance of transparency while burying contradictions. Another is relying on management dashboards without checking source records. Founders should preserve exports, definitions, historical revisions, and audit trails. Buyers should ask why a metric changed, whether it was restated, and which customer or employee supplied the underlying data. It is also a mistake to ask only whether a product is “AI.” The better question is what decision or workflow changes because of the system, how the result is verified, and what happens when it fails.

A second mistake is allowing AI tools to make final legal, financial, or compliance decisions. Automation can identify a possible issue, but it cannot determine legal meaning, explain a regulator’s intent, or guarantee that a technical test represents production. A third mistake is neglecting people diligence. Key-person risk, sales concentration, employee classification, security training, retention plans, and founder transition can be more decisive than model architecture. The provided research context specifically warns about excessive reliance on someone else doing diligence and losing attention to other pressing matters; that warning applies directly to AI-assisted review. The tool should be accountable to a named reviewer.

Walk-away or reprice the transaction when a core value driver cannot be verified, when the target has knowingly misrepresented a material metric, when customer contracts prevent the planned use of data or technology, or when security and regulatory exposure lacks a credible remediation plan. Do not walk away merely because a system uses an external model, lacks a patent, or has a lower evaluation score than a competitor. Those facts require context. The decisive question is whether the business can deliver a valuable, lawful, and economically sustainable product after closing.

The 2026 Decision Rule for Founders and Operators

The best time to use an AI deal diligence checklist is before a formal process begins. Founders who prepare 60 to 90 days in advance can resolve document gaps, quantify customer concentration, separate recurring revenue from pilots, and present a defensible model of unit economics. The best time for buyers to involve AI tools is at the start of document collection, when they can structure the data room and identify missing evidence. They should still reserve human judgment for valuation, privilege, regulatory interpretation, and final negotiation. A target preparing for diligence in 2026 should not optimize for sounding sophisticated; it should optimize for being easy to verify.

The practical standard is simple: every important claim should have a source, every source should have a reviewer, and every unresolved gap should have a financial consequence. In a transaction involving a €25 million to €250 million health-tech, med-tech, healthcare-AI, or health-IT company, buyers may examine clinical validation, patient-data governance, security, reimbursement, and implementation capacity in addition to ordinary software metrics. In venture or private deal flow, founders can use the same discipline to screen counterparties and communicate risk before time is spent on a transaction that cannot close. AI can make that process faster, but it cannot make an unverified fact true.